Akanda Corp. (AKAN) vs Aspire Biopharma Holdings, Inc. (ASBP)
A side-by-side comparison of Akanda Corp. and Aspire Biopharma Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AKAN
Akanda Corp.
$1.95HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
ASBP
Aspire Biopharma Holdings, Inc.
$8.77HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — AKAN vs ASBP
growth of $100 · dividends reinvested · last 4yAKAN -100.0% (-95.4%/yr)ASBP -99.9% (-83.5%/yr)ASBP compounded faster over this window
Log scale — wide-divergence pair
AKAN ASBP
AKAN vs ASBP: by the numbers
- •ASBP is the larger company ($1M vs $63114 market cap).
- •Both run net losses; ASBP's is the smaller (-11314.24% vs -17690.19% net margin).
Metrics side by side
Valuation
| Metric | AKAN | ASBP |
|---|---|---|
| P/S ratio | N/A | 10.36 |
| P/B ratio | N/A | 0.09 |
Profitability
| Metric | AKAN | ASBP |
|---|---|---|
| Gross margin | -60.46% | -1.87% |
| Operating margin | -1930.99% | -312016.95% |
| Net margin | -17690.19% | -11314.24% |
| ROE | N/A | -93.97% |
| ROIC | -242.09% | -59.81% |
Growth (annualized)
| Metric | AKAN | ASBP |
|---|---|---|
| Revenue CAGR (5Y) | 162.75% | N/A |
Go deeper
Dig into the metrics
Akanda ROEAspire Biopharma ROEAkanda operating marginAspire Biopharma operating marginAkanda revenue growthAspire Biopharma revenue growthAkanda free cash flowAspire Biopharma free cash flow
Akanda & Aspire Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.